Rare diseases
Investigational molecules
Locations
Back to Portugal27 clinical trials in Matosinhos, Portugal across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections
PortugalStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
PortugalA study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis
PortugalStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
PortugalStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
PortugalStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
PortugalStudy on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PortugalStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
PortugalStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
PortugalStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
PortugalLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
PortugalStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Frontotemporal Dementia and various forms of Multiple Sclerosis, including primary progressive and secondary progressive variants. Studies are evaluating novel therapeutic approaches and long-term treatment options.
Clinical investigations include assessment of new compounds for refractory focal onset epilepsy and progressive neurological conditions.
Comprehensive studies addressing Pulmonary Fibrosis and chronic respiratory conditions. Research focuses on innovative treatments for chronic rhinosinusitis and progressive lung diseases.
Trials aim to improve lung function and reduce disease progression in various respiratory conditions.
Advanced research in Heart Failure and stroke prevention, particularly focusing on patients with atrial fibrillation. Studies evaluate new treatment combinations and preventive strategies.
Research includes comparative studies of new medications for cardiac conditions and prevention strategies.
Targeted studies on Neuroendocrine Cancers, including small cell lung cancer and other specialized cancer types. Research focuses on advanced treatment options for patients with limited therapeutic alternatives.
Trials evaluate new therapeutic approaches for patients who have progressed after standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
